BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 18024433)

  • 1. Novel binding site for Src homology 2-containing protein-tyrosine phosphatase-1 in CD22 activated by B lymphocyte stimulation with antigen.
    Zhu C; Sato M; Yanagisawa T; Fujimoto M; Adachi T; Tsubata T
    J Biol Chem; 2008 Jan; 283(3):1653-1659. PubMed ID: 18024433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Besides an ITIM/SHP-1-dependent pathway, CD22 collaborates with Grb2 and plasma membrane calcium-ATPase in an ITIM/SHP-1-independent pathway of attenuation of Ca2+i signal in B cells.
    Chen J; Wang H; Xu WP; Wei SS; Li HJ; Mei YQ; Li YG; Wang YP
    Oncotarget; 2016 Aug; 7(35):56129-56146. PubMed ID: 27276708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD22 regulates B cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1.
    Otipoby KL; Draves KE; Clark EA
    J Biol Chem; 2001 Nov; 276(47):44315-22. PubMed ID: 11551923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Protein Tyrosine Phosphatase SHP-1 (PTPN6) but Not CD45 (PTPRC) Is Essential for the Ligand-Mediated Regulation of CD22 in BCR-Ligated B Cells.
    Alborzian Deh Sheikh A; Akatsu C; Abdu-Allah HHM; Suganuma Y; Imamura A; Ando H; Takematsu H; Ishida H; Tsubata T
    J Immunol; 2021 Jun; 206(11):2544-2551. PubMed ID: 33990399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux.
    Poe JC; Fujimoto M; Jansen PJ; Miller AS; Tedder TF
    J Biol Chem; 2000 Jun; 275(23):17420-7. PubMed ID: 10748054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell antigen receptor and CD40 differentially regulate CD22 tyrosine phosphorylation.
    Fujimoto M; Kuwano Y; Watanabe R; Asashima N; Nakashima H; Yoshitake S; Okochi H; Tamaki K; Poe JC; Tedder TF; Sato S
    J Immunol; 2006 Jan; 176(2):873-9. PubMed ID: 16393971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells.
    Fleischer SJ; Daridon C; Fleischer V; Lipsky PE; Dörner T
    Arthritis Rheumatol; 2016 May; 68(5):1210-21. PubMed ID: 26713408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling.
    Henshall TL; Jones KL; Wilkinson R; Jackson DE
    J Immunol; 2001 Mar; 166(5):3098-106. PubMed ID: 11207261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment.
    Haga CL; Ehrhardt GR; Boohaker RJ; Davis RS; Cooper MD
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9770-5. PubMed ID: 17522256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.
    Law CL; Sidorenko SP; Chandran KA; Zhao Z; Shen SH; Fischer EH; Clark EA
    J Exp Med; 1996 Feb; 183(2):547-60. PubMed ID: 8627166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHP-1 requires inhibitory co-receptors to down-modulate B cell antigen receptor-mediated phosphorylation of cellular substrates.
    Adachi T; Wienands J; Wakabayashi C; Yakura H; Reth M; Tsubata T
    J Biol Chem; 2001 Jul; 276(28):26648-55. PubMed ID: 11356834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling.
    Grewal PK; Boton M; Ramirez K; Collins BE; Saito A; Green RS; Ohtsubo K; Chui D; Marth JD
    Mol Cell Biol; 2006 Jul; 26(13):4970-81. PubMed ID: 16782884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
    Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
    J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actin tyrosine dephosphorylation by the Src homology 1-containing protein tyrosine phosphatase is essential for actin depolymerization after membrane IgM cross-linking.
    Baba T; Fusaki N; Shinya N; Iwamatsu A; Hozumi N
    J Immunol; 2003 Apr; 170(7):3762-8. PubMed ID: 12646642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD45 regulates tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1.
    Greer SF; Justement LB
    J Immunol; 1999 May; 162(9):5278-86. PubMed ID: 10228003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1.
    Wu Y; Nadler MJ; Brennan LA; Gish GD; Timms JF; Fusaki N; Jongstra-Bilen J; Tada N; Pawson T; Wither J; Neel BG; Hozumi N
    Curr Biol; 1998 Sep; 8(18):1009-17. PubMed ID: 9740800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation.
    Nakamura K; Cambier JC
    J Immunol; 1998 Jul; 161(2):684-91. PubMed ID: 9670943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition of the sites of interaction between the protein tyrosine phosphatase SHP-1 and CD22.
    Blasioli J; Paust S; Thomas ML
    J Biol Chem; 1999 Jan; 274(4):2303-7. PubMed ID: 9890995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions.
    Nitschke L
    Immunol Rev; 2009 Jul; 230(1):128-43. PubMed ID: 19594633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand Recognition Determines the Role of Inhibitory B Cell Co-receptors in the Regulation of B Cell Homeostasis and Autoimmunity.
    Tsubata T
    Front Immunol; 2018; 9():2276. PubMed ID: 30333834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.